
494 Section VI • Liver
◆ Lymphovascular and biliary structures enter the liver through the hepatoduodenal ligament
that courses between the duodenum into the base of segments IV and V, which is termed
the porta hepatis. The portal triad of microanatomy is matched by the gross anatomic orien-
tation in the hepatoduodenal ligament—composed of hepatic artery, portal vein, and bile
duct. Each structure divides into a left and right branch and then arborizes within the liver
in a pattern defi ned by the segments (see Figures 46-1 and 46-2).
◆ Venous drainage of the liver is primarily located at the superior aspect of the liver in the
midline in short structures between the vena cava and the liver. The left, middle, and right
hepatic veins each enter the vena cava within 2 to 4 cm of one another in a coronal orienta-
tion. One or all of these venous elements may be intrahepatic or may have exceedingly
short extrahepatic components. This anatomic feature raises considerably the risk of uncon-
trolled hemorrhage during dissection and resection (see Figure 46-2). In addition to these
three venous structures, there are between 2 and 20 tiny tributaries between the posterior
surface of the liver and the contiguous vena cava. These must be divided to fully mobilize
the right liver.
INDICATIONS
◆ Left hepatic lobectomy is performed primarily for the treatment of malignant disease, which
includes hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and a variety of meta-
static lesions—most commonly of abdominal origin. The best outcomes are achieved in
patients with metastatic lesions from carcinoma of the colon and rectum.
◆ However, the procedure is also performed for benign diseases, such as cystadenoma of the
liver, giant hemangioma of the liver, and intrahepatic biliary strictures existing primarily
on the left side of the biliary tree, and at times for lesions such as either hepatic adenoma
or focal nodular hyperplasia determined to be clinically signifi cant, perhaps because of
increasing size.
STEP 2: PREOPERATIVE CONSIDERATIONS
◆ Due to the magnitude of hepatic surgery, one fi rst consideration is the medical status of the
patient and likely risk of surgery. Thus one must exclude signifi cant coronary, pulmonary,
or renal disease or age and frailty. Of particular concern in relation to hepatic surgery is the
underlying hepatic function. Because hepatocellular carcinoma is associated with prior hep-
atitis and cirrhosis, one must determine fi rst whether cirrhosis exists and second what level
of function is apparent. Historically, this was measured by examining synthetic and excre-
tory functions and measures of portal hypertension (serum albumin level, coagulation pro-
fi le, serum bilirubin level, ascites, and mental status/serum ammonia). More recently, the
Model for End-Stage Liver Disease (MELD) score was developed as a means of segregating
candidates for liver transplant. This system incorporates prior variables but has added and
places considerable signifi cance to renal function. Particularly when one anticipates a major
resection one must establish that suffi cient liver will remain to support life. Unfortunately,
this estimate of “hepatic reserve” is even today an inexact science.